Company news
Starpharma Holdings Limited news in 2021
Starpharma Holdings Limited's news releases, calls and decks from 2021, newest first.
VIRALEZE successfully launched in Vietnam
December 13, 2021
Starpharma signs DEP Research Agreement with US Biopharma Co
December 6, 2021
VIRALEZE distribution agreement and launch in Vietnam
December 2, 2021
VIRALEZE registered in Vietnam with launch this week
November 30, 2021
AGM Chairman address and CEO presentation
November 29, 2021
Positive DEP phase 2 interim results in prostate cancer
November 25, 2021
VIRALEZE distribution and supply to Vietnam
October 25, 2021
VIRALEZE launch in ADMENTA Italia Group pharmacies in Italy
October 7, 2021
VIRALEZE Protects Against SARS-CoV-2 in Challenge Model
August 23, 2021
VIRALEZE well tolerated in multiple dose clinical study
August 17, 2021
VIRALEZE SPL7013 virucidal against SARS-CoV-2 Delta variant
July 27, 2021
VIRALEZE UK Update
June 20, 2021
VIRALEZE SPL7013 virucidal against multiple COVID variants
June 17, 2021
VIRALEZE antiviral nasal spray registered for sale in India
June 11, 2021
VIRALEZE SPL7013 highly active in UK variant of coronavirus
June 1, 2021
VIRALEZE launches in Europe
May 6, 2021
VIRALEZE™ now launched by LloydsPharmacy in the UK
March 29, 2021
VIRALEZE to be launched with LloydsPharmacy in the UK
March 24, 2021
DEP HER2-lutetium outperforms in human breast cancer model
March 15, 2021
VIRALEZE antiviral nasal spray registered in Europe
February 22, 2021
Starpharma signs DEP ADC Research Agreement with MSD
February 11, 2021
AZD0466 clinical DEP program global expansion
February 8, 2021
Change in substantial holding
February 2, 2021
Decks in 2021
- Shareholder Meeting (November 2021)
Shareholder meeting · 41 slides · Nov 30, 2021